Scalable CRISPR-Cas9 chemical genetic screens in non-transformed human cells

STAR Protoc. 2022 Dec 16;3(4):101675. doi: 10.1016/j.xpro.2022.101675. Epub 2022 Sep 14.

Abstract

Pooled lentiviral CRISPR-Cas9 screens are utilized for assessing the differential sensitivity or resistance of many single-gene knockouts to a compound. Here, we present a scalable approach for high-throughput compound screening by utilizing a small custom library. We describe steps to perform a proof-of-principle chemical screen in non-transformed hTERT RPE-1 TP53-/- cells with higher coverage and greater timepoint resolution compared to genome-wide screens. This approach can be adapted for use in various cell lines, compounds, and other focused sgRNA libraries.

Keywords: CRISPR; Genomics; High Throughput Screening; Molecular Biology; Sequencing.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • CRISPR-Cas Systems*
  • Gene Knockout Techniques
  • Gene Library
  • Genetic Testing*
  • Genome
  • Humans